SCHEMBL4474737

SCHEMBL4474737

ClC(Cl)(c1cccc(Br)c1)c1cccc(Br)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA5A P35218 1/20 0.47
CA9 Q16790 1/20 0.47
ALDH1A1 P00352 3/20 0.42
MAPK1 P28482 1/20 0.42
KIF11 P52732 1/20 0.42
TSHR P16473 1/20 0.36
TAAR1 Q96RJ0 2/20 0.35
C1S P09871 1/20 0.35
PARP1 P09874 1/20 0.35
PGK1 P00558 1/20 0.35
PGK2 P07205 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
IDO1 P14902 2/20 0.34
AGXT P21549 2/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM1A O60341 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11864924 0.93 KIF11 (0.46) CA1CA2CA5ACA9ALDH1A1
SCHEMBL11540480 0.85 TSHR (0.48) CA1CA2CA5ACA9ALDH1A1
SCHEMBL15352176 0.81 ALDH1A1 (0.44) CA1CA2CA5ACA9ALDH1A1
SCHEMBL11657645 0.79 KIF11 (0.46) CA1CA2CA5ACA9ALDH1A1
SCHEMBL264984 0.75 MEN1 (0.49) CA1CA2CA5ACA9ALDH1A1
SCHEMBL29824423 0.75 CA1 (0.57) CA1CA2CA5ACA9ALDH1A1
SCHEMBL4661 0.75 CA1 (0.57) CA1CA2CA5ACA9ALDH1A1
SCHEMBL29945227 0.75 MEN1 (0.49) CA1CA2CA5ACA9ALDH1A1
SCHEMBL4960783 0.75 CA1 (0.47) CA1CA2CA5ACA9ALDH1A1
SCHEMBL27923503 0.75 ESR1 (0.50) CA1CA2CA5ACA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576088-B2 Benzodioxole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
EP-1532132-B1 NOVEL BENZODIOXOLES HOFFMANN LA ROCHE (CH) 2008-03-19 EP disclosed
US-20050143373-A1 Benzodioxole derivatives ALANINE ALEXANDER (FR) 2005-06-30 US disclosed
US-6900227-B2 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. (US) 2005-05-31 US disclosed
EP-1532132-A1 NOVEL BENZODIOXOLES F.HOFFMANN-LA ROCHE AG (CH) 2005-05-25 EP disclosed
US-20040142922-A1 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. 2004-07-22 US disclosed
WO-2004013120-A1 NOVEL BENZODIOXOLES F. HOFFMANN-LA ROCHE AG (CH) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143373-A1 Benzodioxole derivatives CNR2, CNR1, GPR119 CA1 4154/4885CA2 2364/4885CA5A 956/4885
US-20040142922-A1 Benzodioxole derivatives CNR1, CNR2, GPR119 CA1 3482/4885CA2 2070/4885CA5A 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.